News

Launch

The Cura OT app is live

Cura OT, our app for occupational therapists, is live. Requests for occupational therapy support made through the app are passed to Dignity Access Limited, the official Cura plus reseller for England and Wales.

Illustration of an occupational therapist in navy scrubs using a tablet in an accessible bathroom with a grab rail, as a floor plan appears above her and links to a care icon and a care home outside. Illustrative graphic.
Illustrative data

Cura OT is live. It is our app for occupational therapists who assess homes and recommend adaptations, and it is the first Cura plus product to reach the people it was built for.

Home assessments often involve measuring rooms by hand, sketching layouts and typing notes into a report later. Cura OT is designed to bring those steps together on a single device.

What Cura OT does

Cura OT lets an occupational therapist scan a room with a LiDAR equipped iPhone Pro or iPad Pro and produce a floor plan with measurements. The therapist can add assessment notes and review adaptation options alongside the plan.

Suggestions, with the therapist in charge

Cura OT suggests adaptation options based on the measurements and assessment notes. These are suggestions only. The occupational therapist reviews them and decides on every recommendation, using their own professional judgement and knowledge of the person and their home.

CuraAI is designed to support professional and clinical judgement. It does not make care decisions; your professionals do.

Requests for OT support

Some people using Cura OT will want help from an occupational therapist. Requests for occupational therapy support made through the app are passed to Dignity Access Limited, the official Cura plus reseller for England and Wales, who will be in touch about the request.

Getting started

Cura OT runs on LiDAR equipped iPhone Pro and iPad Pro devices. Pricing is available on request. If you would like to see Cura OT or talk about how it could fit your service, please contact us.

Back to all news